• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problem Occlusion Within Device (1423)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/25/2017
Event Type  malfunction  
Manufacturer Narrative
Other applicable components are: product id 8709, serial# (b)(4), implanted: (b)(6) 2012, product type: catheter.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a healthcare provider via a clinical study regarding a patient receiving dilaudid (750.0 mcg/ml at 250.03 mcg/day), bupivacaine (15.0 mg/ml at 5.001 mg/day) and clonidine (75.0 mcg/ml at 25.003 mcg/day) via an implanted pump.The indication for use was non-malignant pain and cervical radiculopathy.It was reported during a pump replacement, on (b)(6) 2017, secondary to normal battery depletion, a catheter occlusion was observer at the distal ports of the catheter tip.The occlusion was cleared with saline during pump replacement surgery.It was indicated the event was related to the device or therapy.The issue resolved without sequelae on (b)(6) 2017.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from a healthcare provider via a clinical study updated the drugs the patient was receiving at the time of the event to dilaudid (750.0 mcg/ml at 249.57 mcg/day), bupivacaine (15.0 mg/ml at 4.991 mg/day) and clonidine (75.0 mcg/ml at 24.957 mcg/day).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from a healthcare provider via a clinical study reported the cause of the catheter occlusion was not determined and the patient's baseline weight was not measured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer (Section G)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7175144
MDR Text Key97667427
Report Number3004209178-2018-00451
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/01/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/28/2013
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/08/2018
Initial Date FDA Received01/09/2018
Supplement Dates Manufacturer Received01/17/2018
01/31/2018
Supplement Dates FDA Received01/18/2018
02/01/2018
Date Device Manufactured12/01/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age54 YR
-
-